Recent News

By Category: Biotechnology

Global Green, Inc. Initiates Advanced Trial in Quest of Salmonella-Free Egg

(MarketWire) Global Green, Inc. announced today that the Company has initiated an advanced trial for its patented, exclusively-licensed vaccine, Salmogenics. The purpose of the study is to determine how long a chicken can be protected against Salmonella after it begins laying eggs. If a layer hen is not infected with the Salmonella bacteria, then neither the Read More »

August 9, 2012
| Filed under North America, Agriculture, Biotechnology, and Research
Share

New Inventory Tracks Synthetic Biology Applications

(Synthetic Biology Project) New technologies are often defined by a few iconic examples that capture the public imagination. While nanotechnology was defined in the early days by its applications like stain-resistant clothing and sunscreens, it took longer to realize that nanoscale science and engineering were having pervasive impacts across multiple economic sectors and products and creating Read More »

August 7, 2012
| Filed under North America, Biotechnology, and Policy & Initiatives
Share

Navy to Shift WMD Surveillance Activities

(Global Security Newswire) The U.S. Navy on Thursday said it would relocate an Indiana installation’s chemical, biological and radiological arms surveillance activities to a facility in Dahlgren, Va. The planned transfer of programs from Crane, Ind., to Naval Surface War Center Dahlgren Division is intended to centralize efforts and cut operational expenses, the service said Read More »

August 6, 2012
| Filed under North America, Biotechnology, and Countermeasures
Share

Synthetic Biology Expands Beyond Bacteria

(GEN) Synthetic biology is getting a boost. So far, most researchers have designed their synthetic circuits using transcription factors found in bacteria. However, these don’t always translate well to nonbacterial cells and can be a challenge to scale. Now, researchers have come up with a new method to design transcription factors for nonbacterial cells—specifically yeast. Their initial Read More »

August 3, 2012
| Filed under North America, Biotechnology, and Research
Share

Soligenix Announces Collaboration with Infectious Disease Research Institute … – MarketWatch (press release)

Soligenix Announces Collaboration with Infectious Disease Research Institute …MarketWatch (press release)"IDRI is enthusiastic about working with Soligenix to support their efforts in developing their anthrax and ricin vaccine candidates, and are highly confident that IDRI's adjuvant technology can help build effective vaccines," said Darrick Carter PhD …